Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
Secondary progressive multiple sclerosis (SPRS) represents an important stage in the development of multiple sclerosis, but is often difficult to diagnose accurately. A study conducted in five European countries used objective classifiers to determine the proportion and characteristics of SPRS in different registries of multiple sclerosis patients, including the national ReMuS registry. The findings suggest ...
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
In a recent study published in Multiple Sclerosis and Related Disorders, researchers examined the risk of relapse in patients with multiple sclerosis (MS) and neuromyelitis optica (NMOSD) after vaccination against COVID-19 and after undergoing COVID-19. The study looked at data from the Czech national ReMuS registry and showed...
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
Multiple sclerosis can also affect children, although it is a rarer form of the disease. Approximately 3-10 % patients will develop multiple sclerosis before the age of 16. This study focuses on the analysis of a group of pediatric patients with relapsing form of multiple sclerosis who started treatment...
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1,533 pregnancies in Czech Republic
Pregnancy in patients with multiple sclerosis (MS) requires special care, particularly with regard to decisions regarding disease-modifying disease (DMD) treatment and counselling regarding the period of conception, pregnancy and the postpartum period. This study aims to analyze the impact of pregnancy, childbirth or miscarriage on the course of multiple sclerosis ...
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia
The emergence of the novel coronavirus COVID-19 has raised concerns about the course of this disease in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). This study aimed to evaluate the incidence, severity, and risk factors for a more severe course of COVID-19 among patients with MS and NMOSD ...
COVID-19 and multiple sclerosis under scrutiny | ReMuS 2021 registry press conference
Exactly 1,918 patients with multiple sclerosis (MS) who have also contracted coronavirus are being closely monitored by doctors in the ReMuS Multiple Sclerosis Patient Registry. Since March last year, they have been investigating the symptoms, treatment and possible impact of coronavirus on this specific group of people. Initial analyses show that MS is not a risk factor, but patients who are older, have more severe neurological impairment, are obese and also have some type of chronic therapy are at higher risk...
Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
This study focuses on the description of treatment interruptions and discontinuations in the Big Multiple Sclerosis Data Network registry group. This cohort study, led by Prof. Jan Hillert from Karolinska Institutet, Sweden, pooled data from five clinical registries covering a period of 20 years....
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. After the first demyelinating episode, well-established drugs are commonly used in MS patients in the Czech Republic...
What data does the national registry of patients with multiple sclerosis ReMuS offer?
In a review article of the professional journal Neurology for Practice, the expert guarantor of the ReMuS registry focused on the introduction of the ReMuS registry and especially the range of data contained in it. The article also offers insight into the representation of patients in individual MS centres in the Czech Republic, the development of the deployment of highly effective drugs or the very important area of...
Multiple Sclerosis Patient Registry ReMuS - the importance of data in chronic diseases
A new article in the professional journal Remedia provides information on what can be found in the data of the ReMuS multiple sclerosis patient registry and in real clinical practice in the Czech Republic after six years of operation. Since its inception, the records are available...